print this page

Clinical Trials: Infection


A Multi-center, randomized, double-blind study to compare the efficacy and safety of cadazolid versus vancomycin in subjects with Clostridium Difficile-associated diarrhea (CDAD) (IRB# 566849)

(Infection)
  • Principal Investor
    Patrick Lee, MD
  • Summary

    The purpose of this study is to see if an investigational medication, cadazolid, is safe and more effective than vancomycin for the treatment of clostridium difficile-associated diarrhea (C-Diff). Participants in this trial will take either cadazolid or vancomycin for 10 days.

  • More Information

    Eligibility:

    To participate in this trial you must be 18 years or older and have diagnosis of Clostridium Difficile with active diarrhea.

  • Study Site Location
    Baystate Medical Center
  • Contact
    Courtney Reyes, RN
    413.794.2412
    Email